Atlas Venture Fund XI, L.P. → Korro Bio, Inc. KRRO

Stake: — Shares: 706,556 Class: Common Stock, par value $0.001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 28/100

Active Schedule 13D filer baseline
Elevated short days-to-cover (9.6 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

4 transactions

4 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 9.63

1,732,855 shares short · +3.4% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-15	Vincent Loic A	officer	Award	7,500	—	—
2026-07-15	Dolan Oliver	officer	Award	5,500	—	—
2026-07-15	Cerio Jeffrey	officer	Award	6,500	—	—
2026-07-15	Chappell Todd	officer	Award	7,500	—	—

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →